SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-107558
Filing Date
2021-04-06
Accepted
2021-04-06 16:02:06
Documents
12
Period of Report
2021-04-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d17277d8k.htm   iXBRL 8-K 22415
  Complete submission text file 0001193125-21-107558.txt   140506

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA agen-20210405.xsd EX-101.SCH 3072
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20210405_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20210405_pre.xml EX-101.PRE 10954
5 EXTRACTED XBRL INSTANCE DOCUMENT d17277d8k_htm.xml XML 3303
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 21809210
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences